(Q34664459)

3 August 2017

title

FTY720 inhibits tubulointerstitial inflammation in albumin overload-induced nephropathy of rats via the Sphk1 pathway (English)

1 reference

3 August 2017

0 references

1 reference

Min Xu

1

1 reference

3 August 2017

Dan Liu

2

1 reference

3 August 2017

Li-hong Ding

3

1 reference

3 August 2017

Kun-ling Ma

4

1 reference

3 August 2017

Min Wu

5

1 reference

3 August 2017

Lin-li Lv

6

1 reference

3 August 2017

Yi Wen

7

1 reference

3 August 2017

Hong Liu

8

1 reference

3 August 2017

Ri-ning Tang

9

1 reference

3 August 2017

Bi-cheng Liu

10

1 reference

3 August 2017

publication date

17 November 2014

1 reference

Acta Pharmacologica Sinica

3 August 2017

published in

1 reference

3 August 2017

volume

35

1 reference

3 August 2017

issue

12

1 reference

3 August 2017

page(s)

1537-1545

1 reference

Enalapril inhibits tubulointerstitial inflammation and NLRP3 inflammasome expression in BSA-overload nephropathy of rats

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

Circulating monocytes are reduced by sphingosine-1-phosphate receptor modulators independently of S1P3.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

Proteinuria: detection and role in native renal disease progression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

Mechanistic connection between inflammation and fibrosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

Sphingosine kinase: Role in regulation of bioactive sphingolipid mediators in inflammation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

The alliance of sphingosine-1-phosphate and its receptors in immunity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

How does proteinuria cause progressive renal damage?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

Sphingosine 1 phosphate induces the chemotaxis of human natural killer cells. Role for heterotrimeric G proteins and phosphoinositide 3 kinases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

The role of interstitial cells in the progression of renal diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261119

Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis

7 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2014.100

Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2014.100

FTY720 attenuates tubulointerstitial inflammation and fibrosis in subtotally nephrectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2014.100

Calcium citrate ameliorates the progression of chronic renal injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2014.100

Engagement of S1P₁-degradative mechanisms leads to vascular leak in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2014.100

Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2014.100

TLR2 and TLR4 expression after kidney ischemia and reperfusion injury in mice treated with FTY720

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25399649

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The sphingosine-1-phosphate receptor agonist FTY720 prevents the development of anti-glomerular basement membrane glomerulonephritis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25399649

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/APS.2014.100

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference